Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Prot# CSTI571 0110: A Phase II Study to Determine the Efficacy and Safety of STI571 in Patients with Chronic Myeloid Leukemia Who Are Refractory To Or Intolerant Of Interferon-Alpha
Frankfurt, Olga
(PD/PI)
Medicine, Hematology Oncology Division
Project
:
Research project
Overview
Project Details
Status
Finished
Effective start/end date
12/15/99
→
8/31/13
Funding
Novartis Pharmaceuticals Corporation
(CSTI571 0110)
View all
View less